Enterovaginal Fistula After Tofacitinib Administration

Abstract

Get full access to this article

View all access options for this article.

References

Curtis

Lanas

John

Johnson

Schulman

KL.

Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis. Arthritis Care Res. 2012;64:1819-1828.

Strangfeld

Richter

Siegmund

et al . Risk for lower intestinal perforations in patients with rheumatoid arthritis with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARD. Ann Rheum Dis. 2017;76:504-516.

Siegmund

Sennello

Jones-Carson

et al . Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut. 2004;53:965-972.

Khader

Guglani

Th17 cytokines in mucosal immunity and inflammation. Curr Opin HIV AIDS. 2010;5:120-127.

Ghoreschi

Jesson

et al . Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol. 2011;186:4234-4243.

Naranjo

Busto

Sellers

et al . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.